Cas:154487-85-1 N,N,N’,N’-tetrakis[3-[bis[3-(bis(3-aminopropyl)amino)propyl]amino ]propyl]butane-1,4-diamine manufacturer & supplier

Chemical Name:N,N,N’,N’-tetrakis[3-[bis[3-(bis(3-aminopropyl)amino)propyl]amino ]propyl]butane-1,4-diamine

CAS.NO:154487-85-1

Synonyms:16-cade:1,2-diaminobutane[4-N,N,N’,N’]:(1-azabutylidene):(aminopropane);L-Valine-d8;diaminobutane-dend(NH2)16;1,4-bis[bis[3-[bis[3-[bis(3-aminopropyl)amino]propyl]amino]propyl]amino]butane;L-|A-Amino-|A-methylbutyric Acid-d8;(S)-2-Amino-3-methylbutanoic Acid-d8;DAB-3-(NH2)16;D8-L-valine;(+)-2-Amino-3-methylbutyric Acid-d8;(S)-Valine-d8;L-(+)-|A-Aminoisovaleric Acid-d8;(S)-|A-Amino-|A-methylbutyric Acid-d8;DAB-dend-(NH2)16;(2S)-2-Amino-3-methylbutanoic Acid-d8

Molecular Formula:C₈₈H₂₀₈N₃₀

Molecular Weight:1686.79000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.01 g/mL at 25ºC(lit.)

Index of Refraction:n20/D 1.515(lit.)

PSA:461.68000

Exact Mass:1685.72000

LogP:11.46140

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 2735 8/PG 3

Packing Group:

Contact us for information like 16-cade:1,2-diaminobutane[4-N,N,N’,N’]:(1-azabutylidene):(aminopropane) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2S)-2-Amino-3-methylbutanoic Acid-d8 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2S)-2-Amino-3-methylbutanoic Acid-d8 Use and application,D8-L-valine technical grade,usp/ep/jp grade.

Related News: It’s the first confirmed Wuhan coronavirus death from outside of mainland China, and brings the total toll to 305. N,N,N’,N’-tetrakis[3-[bis[3-(bis(3-aminopropyl)amino)propyl]amino ]propyl]butane-1,4-diamine manufacturer It’s the first confirmed Wuhan coronavirus death from outside of mainland China, and brings the total toll to 305. N,N,N’,N’-tetrakis[3-[bis[3-(bis(3-aminopropyl)amino)propyl]amino ]propyl]butane-1,4-diamine supplier Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. N,N,N’,N’-tetrakis[3-[bis[3-(bis(3-aminopropyl)amino)propyl]amino ]propyl]butane-1,4-diamine vendor Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. N,N,N’,N’-tetrakis[3-[bis[3-(bis(3-aminopropyl)amino)propyl]amino ]propyl]butane-1,4-diamine factory he agency said the drugmaker and Emergent must agree that the FDA can share relevant information about the manufacturing of the doses with regulators where the vaccine is shipped.